Aquestive Therapeutics In... (AQST)
Aquestive Therapeutics Max Pain By Strike
AQST trades at $3.88, 55.2% above the near-term max pain of $2.5 expiring Sep 19, 2025 (29 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$60), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Aquestive Therapeutics Max Pain By Expiry
Max pain for AQST shows a downward trend from 60 to 2.5, indicating bearish sentiment or hedging activity. The 411% spread signals divergent expectations across timeframes. Most levels below 3.88 may cap rallies. Strong magnetic level at 3 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 2.5 | -1.38 (-35.57%) |
| Oct 17, 2025 | 2.5 | -1.38 (-35.57%) |
| Nov 21, 2025 | 2.5 | -1.38 (-35.57%) |
| Jan 16, 2026 | 60 | 56.12 (1446.39%) |
| Feb 20, 2026 | 2.5 | -1.38 (-35.57%) |